Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Revenue | ||||
Total revenue | $ 28,446 | $ 57,809 | $ 162,092 | $ 94,931 |
Cost of goods sold | ||||
Cost of goods sold | 77,534 | 8,477 | 98,500 | 15,010 |
Total cost of goods sold | 77,534 | 8,477 | 98,500 | 15,010 |
Gross Profit | (49,088) | 49,332 | 63,592 | 79,921 |
Operating expenses: | ||||
Warranty expense | ||||
Depreciation and amortization | 95,448 | 72,557 | 190,783 | 143,036 |
Bad Debt Expense | 6,000 | 6,000 | ||
Legal and professional fees | 83,780 | 255,048 | 85,559 | 356,002 |
Payroll expense | 88,230 | 58,937 | 219,501 | 84,104 |
Selling and marketing expense | 2,220 | 30,544 | 20,779 | 30,920 |
Selling and marketing expense, related party | ||||
Consulting | 27,239 | 44,180 | ||
Consulting, related party | 45,000 | 91,000 | ||
Royalty expense | (3,805) | 11,472 | ||
License royalties | ||||
General and administrative | 64,776 | 9,184 | 150,096 | 68,412 |
Research and development | 397,500 | 48,200 | 732,000 | |
Total operating expenses | 408,889 | 823,770 | 867,570 | 1,414,474 |
Other (income) expense: | ||||
Gain on PPP loan forgiven | (146,959) | (443,873) | ||
Loss on debt settlement | ||||
Interest expense and finance costs | 176,640 | 918,807 | 410,164 | 1,045,638 |
Total other (income) expense | 176,640 | 771,848 | 410,164 | 601,765 |
Net loss | $ (634,617) | $ (1,546,286) | $ (1,214,142) | $ (1,936,318) |
Net loss per common share – basic and diluted | $ (0.00) | $ (0.01) | $ (0.01) | $ (0.01) |
Weighted average common | 231,509,068 | 224,213,846 | 231,507,112 | 224,213,846 |
Sales Net [Member] | ||||
Revenue | ||||
Total revenue | $ 28,446 | $ 57,809 | $ 162,092 | $ 94,931 |
X | ||||||||||
- Definition Consulting expense. No definition available.
|
X | ||||||||||
- Definition Gain on ppp loan forgiven. No definition available.
|
X | ||||||||||
- Definition License royalties. No definition available.
|
X | ||||||||||
- Definition Other selling general and administrative expense related party. No definition available.
|
X | ||||||||||
- Definition Product warranty expenses. No definition available.
|
X | ||||||||||
- Definition Royalty expense. No definition available.
|
X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of interest expense on finance lease liability. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense (reversal of expense) for expected credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|